World-first gene therapy for 2 blood disorders — sickle cell and thalassemia — approved November 16, 2023 Britain's medical regulator has announced it's authorized a gene therapy for sickle-cell disease and another type of inherited blood disorder for patients aged 12 and over. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.